Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Funda Meric-Bernstam

Showing results (621-630 of 643) with videos related to

Pageof 65
Sort By:
Science Advances|February 9, 2022
A functional genomic approach to actionable gene fusions for precision oncologyJun Li, Hengyu Lu, Patrick Kwok-Shing Ng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2025
Clinicogenomic Characterization of Primary Sclerosing Cholangitis-Associated Biliary Tract CancersXin Wang, Jaime Ivan Haro-Silerio, Felix Emile Gastonguay Beaudry, et al.
Nature Immunology|June 5, 2019
Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppressionQingsong Hu, Youqiong Ye, Li-Chuan Chan, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Patient-Derived Xenografts of Triple-Negative Breast Cancer Enable Deconvolution and Prediction of Chemotherapy ResponsesJonathan T Lei, Lacey E Dobrolecki, Chen Huang, et al.
Journal for Immunotherapy of Cancer|March 20, 2020
Phase 2 study of pembrolizumab in patients with advanced rare cancersAung Naing, Funda Meric-Bernstam, Bettzy Stephen, et al.
The New England Journal of Medicine|February 22, 2018
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and ChildrenAlexander Drilon, Theodore W Laetsch, Shivaani Kummar, et al.
Journal of the National Cancer Institute|January 11, 2020
The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial DesignKeith T Flaherty, Robert Gray, Alice Chen, et al.
The Journal of Investigative Dermatology|August 23, 2014
Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanomaAlan E Siroy, Genevieve M Boland, Denái R Milton, et al.
Cancer Cell|March 14, 2018
Systematic Functional Annotation of Somatic Mutations in CancerPatrick Kwok-Shing Ng, Jun Li, Kang Jin Jeong, et al.
Cancer Research|December 15, 2023
Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell CarcinomaYige Wu, Siqi Chen, Xiaolu Yang, et al.
Pageof 65

Showing results (621-630 of 643) with videos related to

Sort By:
Pageof 65
Science Advances|February 9, 2022
A functional genomic approach to actionable gene fusions for precision oncologyJun Li, Hengyu Lu, Patrick Kwok-Shing Ng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2025
Clinicogenomic Characterization of Primary Sclerosing Cholangitis-Associated Biliary Tract CancersXin Wang, Jaime Ivan Haro-Silerio, Felix Emile Gastonguay Beaudry, et al.
Nature Immunology|June 5, 2019
Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppressionQingsong Hu, Youqiong Ye, Li-Chuan Chan, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Patient-Derived Xenografts of Triple-Negative Breast Cancer Enable Deconvolution and Prediction of Chemotherapy ResponsesJonathan T Lei, Lacey E Dobrolecki, Chen Huang, et al.
Journal for Immunotherapy of Cancer|March 20, 2020
Phase 2 study of pembrolizumab in patients with advanced rare cancersAung Naing, Funda Meric-Bernstam, Bettzy Stephen, et al.
The New England Journal of Medicine|February 22, 2018
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and ChildrenAlexander Drilon, Theodore W Laetsch, Shivaani Kummar, et al.
Journal of the National Cancer Institute|January 11, 2020
The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial DesignKeith T Flaherty, Robert Gray, Alice Chen, et al.
The Journal of Investigative Dermatology|August 23, 2014
Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanomaAlan E Siroy, Genevieve M Boland, Denái R Milton, et al.
Cancer Cell|March 14, 2018
Systematic Functional Annotation of Somatic Mutations in CancerPatrick Kwok-Shing Ng, Jun Li, Kang Jin Jeong, et al.
Cancer Research|December 15, 2023
Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell CarcinomaYige Wu, Siqi Chen, Xiaolu Yang, et al.
Pageof 65